Cardiovascular and Renal Support: Clinical Breakthroughs
In 2026, FIR therapy has moved into specialized hospital wards, particularly for Heart Failure and Dialysis patients.
Waon Therapy: This Japanese-pioneer method of "soothing warmth" (using FIR at 60°C) is being adopted globally in 2026 to improve cardiac output and reduce systemic vascular resistance in patients with chronic heart failure.
Arteriovenous Fistula (AVF) Health: For patients on hemodialysis, FIR therapy is now the gold standard for maintaining the health of the fistula. FIR exposure (40 mins, 3x/week) significantly improves blood flow through the fistula and reduces the incidence of life-threatening clots (thrombosis).
Anti-Inflammatory Markers: 2026 longitudinal studies show that regular FIR use significantly lowers C-Reactive Protein (CRP) levels, making it a critical adjunct therapy for autoimmune conditions like Rheumatoid Arthritis.